Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInchcape Regulatory News (INCH)

Share Price Information for Inchcape (INCH)

Share Price is delayed by 15 minutes
Get Live Data
804.00    -8.50 (-1.05%)
Bid:
798.50
Ask:
813.50
Spread: 15.00 (1.879%)
Market Cap: £2.83b
INCH Live PriceLast checked at - London Stock Exchange

Intraday Inchcape Share Chart

Update Statement

4 Nov 2025 12:05

RNS Number : 1370G
Inchcape PLC
04 November 2025
 

Inchcape plc

Update Statement

 

At the Annual General Meeting of Inchcape plc ("the Company") held on 15 May 2025, the resolution to approve the Directors' Remuneration Report (resolution 2) passed with 64.55% of votes in favour.

In accordance with Provision 4 of the FRC's 2024 UK Corporate Governance Code, the Company has released this statement to provide an update to shareholders on the actions taken and the views received from shareholders, following the vote.

Prior to the 2025 AGM, the Board of Directors consulted with our largest shareholders and with shareholders' proxy advisers on the Remuneration Committee's implementation decisions in respect of executive remuneration for 2025.

Some shareholders expressed a concern with the salary increase for the Group Chief Executive, which was above workforce average, and the stretch in the performance targets for the one-off PSP award.

Following the AGM, the Chair of the Remuneration Committee wrote to the top 50 shareholders, representing c. 80% of the issued share capital, to provide further rationale for the Remuneration Committee's decisions on these matters. This included a detailed overview of the Group Chief Executive's strategic achievements and the performance required for the one-off PSP targets over the next three years, both of which are integral to the successful execution of the Accelerate+ strategy. Having considered feedback received, the Board is satisfied with its decisions and has concluded that no further actions are necessary.

Also, as part of this consultation, shareholders were also invited to provide their views on proposals for the Remuneration Policy which will be put to shareholder vote at the 2026 AGM. This consultation is on-going, and the feedback received so far, and in respect of the 2024 Remuneration Report, has been helpful in formulating the proposals for the 2026 policy.

The Board is grateful to shareholders for their engagement, and the Board will continue its constructive dialogue with shareholders, considering their feedback when setting remuneration.

An update will be published in our 2025 Annual Report in accordance with the UK Corporate Governance Code, along with the 2026 Remuneration Policy which will be put to shareholder vote at the 2026 AGM.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUPGWUGUPAGPC
Date   Source Headline
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20253:37 pmRNSDirector/PDMR Shareholding
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 202512:25 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20254:31 pmRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSQ1 2025 Trading Update
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20258:36 amRNSDirector/PDMR Shareholding: Performance Share Plan
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20255:55 pmRNSDirector/PDMR Shareholding: Performance Share Plan
16th Apr 20255:50 pmRNSDirector/PDMR Shareholding: Co-Investment Plan
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20251:40 pmRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 202510:04 amRNS2024 Annual Report and 2025 Notice of AGM
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 202510:00 amRNSDirectorate Change
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20253:02 pmRNSDirector/PDMR Shareholding: Market Purchase
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.